Taeko Dohi

Title: Taeko Dohi: Innovator in Glycosphingolipid Research

Introduction

Taeko Dohi is a prominent inventor based in Seattle, WA, known for her significant contributions to the field of glycosphingolipid research. She has developed innovative methods and compositions that have potential applications in cell growth stimulation and medical treatments.

Latest Patents

Taeko Dohi holds a patent for "Naturally occurring gangliosides containing de-N-acetyl-sialic acid." This patent outlines a method for preparing de-N-acylated forms of an N-acyl sugar-containing glycosphingolipid. It describes the hydrolysis of glycosphingolipids under mild alkaline conditions, allowing for the preferential hydrolysis of the N-acyl group of the sugar moiety. The patent also details the isolation of substantially pure gangliosides containing de-N-acetyl-sialic acid from natural sources. Furthermore, it includes a culture medium designed to stimulate the growth of human and animal cells, which comprises essential nutrients and a cell growth stimulatory amount of gangliosides. Additionally, the patent presents a medicament and method for stimulating or inhibiting the growth of human and animal cells by influencing the production of growth stimulators.

Career Highlights

Taeko Dohi is affiliated with The Biomembrane Institute, where she continues her research and development in the field of glycosphingolipids. Her work has garnered attention for its potential impact on cell biology and therapeutic applications.

Collaborations

Taeko has collaborated with notable researchers in her field, including Sen-Itiroh Hakomori and Gustavo A Nores. These collaborations have contributed to the advancement of knowledge and innovation in glycosphingolipid research.

Conclusion

Taeko Dohi's innovative work in glycosphingolipid research highlights her role as a key inventor in the field. Her contributions have the potential to influence both scientific understanding and practical applications in cell growth and medical treatments.